Name | Number of supported studies | Average coverage | |
---|---|---|---|
melanocyte | 7 studies | 70% ± 24% |
Insufficient scRNA-seq data for expression of MLANA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 99% | 692.45 | 1787 / 1809 | 93% | 814.31 | 440 / 472 |
esophagus | 90% | 16.31 | 1304 / 1445 | 58% | 1.10 | 106 / 183 |
stomach | 89% | 16.06 | 319 / 359 | 33% | 0.68 | 93 / 286 |
breast | 90% | 23.53 | 411 / 459 | 21% | 0.42 | 233 / 1118 |
intestine | 93% | 18.02 | 896 / 966 | 14% | 0.31 | 73 / 527 |
adrenal gland | 99% | 21.79 | 255 / 258 | 6% | 0.08 | 13 / 230 |
lung | 93% | 19.04 | 540 / 578 | 11% | 0.28 | 124 / 1155 |
kidney | 91% | 16.72 | 81 / 89 | 9% | 1.05 | 84 / 901 |
eye | 0% | 0 | 0 / 0 | 100% | 2006.16 | 80 / 80 |
spleen | 99% | 21.95 | 238 / 241 | 0% | 0 | 0 / 0 |
ovary | 87% | 14.16 | 157 / 180 | 9% | 0.14 | 40 / 430 |
thymus | 94% | 19.58 | 614 / 653 | 2% | 0.02 | 11 / 605 |
prostate | 92% | 16.33 | 225 / 245 | 3% | 0.07 | 16 / 502 |
liver | 90% | 12.83 | 204 / 226 | 4% | 2.24 | 17 / 406 |
uterus | 88% | 15.16 | 150 / 170 | 6% | 0.30 | 26 / 459 |
adipose | 91% | 17.47 | 1094 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 79% | 11.90 | 259 / 328 | 6% | 0.17 | 11 / 178 |
bladder | 76% | 10.48 | 16 / 21 | 7% | 0.22 | 33 / 504 |
muscle | 79% | 10.92 | 636 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 77% | 11.47 | 1031 / 1335 | 0% | 0 | 0 / 0 |
heart | 71% | 9.42 | 614 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 18.00 | 656 / 929 | 0% | 0 | 0 / 0 |
brain | 49% | 7.12 | 1303 / 2642 | 1% | 0.23 | 9 / 705 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.31 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.13 | 4 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0042470 | Cellular component | melanosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | MLANA |
Protein name | Melanoma antigen recognized by T-cells 1 (MART-1) (Antigen LB39-AA) (Antigen SK29-AA) (Protein Melan-A) |
Synonyms | MART1 |
Description | FUNCTION: Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes. . |
Accessions | Q16655 ENST00000381471.1 ENST00000381476.5 ENST00000381477.8 |